Featured Research

from universities, journals, and other organizations

Latinos more vulnerable to fatty pancreas, type 2 diabetes, study shows

Date:
September 11, 2012
Source:
Cedars-Sinai Medical Center
Summary:
Latinos are more likely to store fat in the pancreas and are less able to compensate by excreting additional insulin, a new study shows.

Latinos are more likely to store fat in the pancreas and are less able to compensate by excreting additional insulin, a Cedars-Sinai study shows.

The research examining overweight, prediabetic patients, published online by Diabetes Care, is part of a focus by Cedars-Sinai's Heart Institute, Biomedical Imaging Research Institute and Diabetes and Obesity Research Institute, to identify biological measures that could help predict which patients are likely to develop type 2 diabetes.

"Prevention of diabetes is our goal," said Richard Bergman, PhD, director of the Cedars-Sinai Diabetes and Obesity Research Institute and a lead author on the study. "Not all people who are overweight or obese and who have insulin resistance go on to develop diabetes. If we can determine who is most likely to develop diabetes and why, then we can make strides toward preventing it in those individuals."

The study compared white, black and Latino participants, similarly overweight and who shared many of the same prediabetic symptoms. It found that Latinos stored fat in their pancreas, which was less able to produce adequate amounts of insulin as compared with white and black study participants. This may be why Latinos are at increased risk of developing Type 2 diabetes.

In chronic obesity, the adipose tissue that is designed to store fat begins to malfunction, allowing fat to spill into the pancreas, liver and skeletal muscle. Some individuals may be insulin resistant throughout their lives but never develop diabetes because their pancreas can compensate by secreting more of the metabolism-regulating hormone. In others, the pancreas cannot compensate, placing these individuals at greater risk of Type 2 diabetes.

"One of the reasons some people are at increased risk, we believe, is that fatty pancreas is unable to secrete enough insulin, which results in an individual progressing from impaired glucose tolerance to Type 2 diabetes," said Lidia Szczepaniak, PhD, director of magnetic resonance spectroscopy at the Cedars-Sinai Heart Institute and Biomedical Imaging Research Institute. "In our study, we found Latinos were especially vulnerable, as they tended to store more fat in the pancreas and their compensatory insulin secretion was entirely suppressed."

The Cedars-Sinai research, for which she was principal investigator, included use of a noninvasive medical imaging technique, known as magnetic resonance spectroscopy, to measure the amount of fat in organs.

In the study, Latino, black and white adults completed three research visits, including an oral glucose tolerance test; they took a frequently sampled intravenous glucose tolerance test to evaluate beta-cell function and insulin resistance; and they underwent magnetic resonance spectroscopy to evaluate fat levels in the pancreas and liver.

According to the Centers for Disease Control and Prevention, diabetes affects 25.8 million people in the United States. An estimated 79 million Americans are prediabetic. Diabetes is the seventh leading cause of death in the United States and a major cause of heart disease and stroke.

The study was supported by National Institute of Health grants RO1 DK081524, K23 RR024470, UL1RR033176 and a grant from the Lincy Foundation.


Story Source:

The above story is based on materials provided by Cedars-Sinai Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lidia S. Szczepaniak, Ronald G. Victor, Ruchi Mathur, Michael D. Nelson, Edward W. Szczepaniak, Nicole Tyer, Ida Chen, Roger H. Unger, Richard N. Bergman, and Ildiko Lingvay. Pancreatic Steatosis and Its Relationship to β-Cell Dysfunction in Humans: Racial and Ethnic Variations. Diabetes Care, 2012; DOI: 10.2337/dc12-0701

Cite This Page:

Cedars-Sinai Medical Center. "Latinos more vulnerable to fatty pancreas, type 2 diabetes, study shows." ScienceDaily. ScienceDaily, 11 September 2012. <www.sciencedaily.com/releases/2012/09/120911102948.htm>.
Cedars-Sinai Medical Center. (2012, September 11). Latinos more vulnerable to fatty pancreas, type 2 diabetes, study shows. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2012/09/120911102948.htm
Cedars-Sinai Medical Center. "Latinos more vulnerable to fatty pancreas, type 2 diabetes, study shows." ScienceDaily. www.sciencedaily.com/releases/2012/09/120911102948.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins